Munich – Wellster, the leading provider of telemedicine platform solutions in the EU, announced today that it closed a $40 million funding round. The round is led by Dermapharm with support from existing investors HV Capital, which previously invested in Zalando, FlixBus and Delivery Hero, and SevenVentures. Ferber & Co. advised and supported Wellster in its funding round.
Wellster is planning to use the funding to expand its offering with additional medical topics and thereby tap into new target groups. In addition further growth opportunities are now opening up for Wellster, such as direct acquisitions of peer companies in the market.
Weitnauer attorney Marc René Spitz provided comprehensive legal advice to Wellster HealthTech Group at the Munich office in this financing round. The in-house legal team for Wellster was led by Group General Counsel Christian Reinert. Weitnauer regularly represents both companies and investors in financing rounds.